Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Dow
Argus Health
Accenture
Baxter
US Department of Justice
Boehringer Ingelheim
Cantor Fitzgerald
Mallinckrodt

Generated: January 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020579

« Back to Dashboard

NDA 020579 describes FLOMAX, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from three suppliers. Additional details are available on the FLOMAX profile page.

The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.
Summary for 020579
Tradename:FLOMAX
Applicant:Sanofi Aventis Us
Ingredient:tamsulosin hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020579
Mechanism of ActionAdrenergic alpha-Antagonists
Suppliers and Packaging for NDA: 020579
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0058 0597-0058-01 100 CAPSULE in 1 BOTTLE (0597-0058-01)
FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579 NDA Bryant Ranch Prepack 63629-3384 63629-3384-1 30 CAPSULE in 1 BOTTLE (63629-3384-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.4MG
Approval Date:Apr 15, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020579

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
Fuji
Covington
Teva
Medtronic
McKinsey
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.